Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum

Neurochemistry International

Volumn 63, Issue 4, 2013, Pages 239-243

  Palotai, Miklós ^a   Bagosi, Zsolt ^a   Jászberényi, Miklós ^a   Csabafi, Krisztina ^a   Dochnal, Roberta ^a   Manczinger, Máté ^a   Telegdy, Gyula ^a   Szabó, Gyula ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Dopamine; Ghrelin; Nicotine; Striatum; Superfusion

Indexed keywords

DOPAMINE; GHRELIN; GHRELIN RECEPTOR; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ELECTROSTIMULATION; IN VITRO STUDY; INTERNEURON; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM;

NICOTIANA TABACUM; RATTUS;

DOPAMINE; GHRELIN; NICOTINE; STRIATUM; SUPERFUSION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; GHRELIN; MALE; NICOTINE; RATS; RATS, WISTAR;

EID: 84882485231     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.06.014     Document Type: Article

References (53)

1. Andrews, Z.B., Erion, D., Beiler, R., Liu, Z.W., Abizaid, A., Zigman, J., Elsworth, J.D., Savitt, J.M., DiMarchi, R., Tschoep, M., Roth, R.H., Gao, X.B., Horvath, T.L., 2009. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. 29, 14057-14065.
2. Anzengruber, D., Klump, K.L., Thornton, L., Brandt, H., Crawford, S., Fichter, M.M., Halmi, K.A., Johnson, C., Kaplan, A.S., LaVia, M., Mitchell, J., Strober, M., Woodside, D.B., Rotondo, A., Berrettini, W.H., Kaye, W.H., Bulik, C.M., 2006. Smoking in eating disorders. Eat. Behav. 7, 291-299. (Pubitemid 44567510)
3. Asakawa, A., Inui, A., Kaga, T., Yuzuriha, H., Nagata, T., Ueno, N., Makino, S., Fujimiya, M., Niijima, A., Fujino, M.A., Kasuga, M., 2001. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120, 337-345. (Pubitemid 32149296)
4. Austin, S.B., Gortmaker, S.L., 2001. Dieting and smoking initiation in early adolescent girls and boys: a prospective study. Am. J. Public Health 91, 446-450. (Pubitemid 32179461)
5. Avena, N.M., Rada, P.V., 2012. Cholinergic modulation of food and drug satiety and withdrawal. Physiol. Behav. 106, 332-336.
6. Balfour, D.J., 2004. The neurobiology of tobacco dependence. a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob. Res. 6, 899-912. (Pubitemid 40124750)
7. Balleine, B.W., Delgado, M.R., Hikosaka, O., 2007. The role of the dorsal striatum in reward and decision-making. J. Neurosci. 27, 8161-8165. (Pubitemid 47219597)
8. Blaha, C.D., Allen, L.F., Das, S., Inglis, W.L., Latimer, M.P., Vincent, S.R., Winn, P., 1996. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J. Neurosci. 16, 714-722.
9. Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D.J., Przybylski, C., Lena, C., Clementi, F., Moretti, M., Rossi, F.M., Le Novere, N., McIntosh, J.M., Gardier, A.M., Changeux, J.P., 2003. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 23, 7820-7829. (Pubitemid 37055453)
10. Chan, C.B., Cheng, C.H., 2004. Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Mol. Cell. Endocrinol. 214, 81-95. (Pubitemid 38210118)
11. Cruz, M.T., Herman, M.A., Cote, D.M., Ryabinin, A.E., Roberto, M., 2013. Ghrelin increases GABAergic transmission and interacts with ethanol actions in the rat central nucleus of the amygdala. Neuropsychopharmacology 38, 364-375.
12. Di Chiara, G., 2000. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393, 295-314. (Pubitemid 30193428)
13. Dickson, S.L., Hrabovszky, E., Hansson, C, Jerlhag, E., Alvarez-Crespo, M., Skibicka, K.P., Molnar, CS., Liposits, Z., Engel, JA, Egecioglu, E., 2010. Blockade of central nicotine acetylcholine receptor signaling attenuate ghrelin-induced food intake in rodents. Neuroscience 171, 1180-1186.
14. Disse, E., Bussier, A.L, Deblon, N., Pfluger, P.T., Tschop, M.H., Laville, M., Rohner-Jeanrenaud, F., 2011. Systemic ghrelin and reward: effect of cholinergic blockade. Physiol. Behav. 102, 481-484.
15. Ferrini, F., Salio, C, Lossi, L., Merighi, A., 2009. Ghrelin in central neurons. Curr. Neuropharmacol. 7, 37-49.
16. Gaddum, J.H., 1953. The technique of superfusion. Br. J. Pharmacol. Chemother. 8, 321-326.
17. Giorguieff-Chesselet, M.F., Kemel, M.L, Wandscheer, D., Glowinski, J., 1979. Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci. 25, 1257-1262.
18. Glennon, RA, Dukat, M., 2000. Central nicotinic receptor ligands and pharmacophores. Pharm. Acta Helv. 74, 103-114. (Pubitemid 30182558)
19. Grilli, M., Patti, L., Robino, F., Zappettini, S., Raiteri, M., Marchi, M., 2008. Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens. J. Neurochem. 105, 2205-2213. (Pubitemid 351782252)
20. Guan, X.M., Yu, H., Palyha, O.C., McKee, K.K., Feighner, S.D., Sirinathsinghji, D.J., Smith, R.G., Van der Ploeg, L.H., Howard, A.D., 1997. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48, 23-29. (Pubitemid 27298124)
21. Haikala, H., Ahtee, L, 1988. Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine. Naunyn Schmiedebergs Arch. Pharmacol. 338, 169-173.
22. Harsing Jr., LG., Vizi, E.S., 1984. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl. Br. J. Pharmacol. 83, 741-749. (Pubitemid 15222087)
23. Haug, N.A., Heinberg, L.J., Guarda, A.S., 2001. Cigarette smoking and its relationship to other substance use among eating disordered inpatients. Eat. Weight Disord. 6, 130-139.
24. Holst, B., Cygankiewicz, A., Jensen, T.H., Ankersen, M., Schwartz, T.W., 2003. High constitutive signaling of the ghrelin receptor - identification of a potent inverse agonist. Mol. Endocrinol. 17, 2201-2210. (Pubitemid 37352532)
25. Janhunen, S., Ahtee, L., 2007. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci. Biobehav. Rev. 31, 287-314. (Pubitemid 46241447)
26. Jerlhag, E., Egecioglu, E., Dickson, S.L, Andersson, M., Svensson, L., Engel, J.A., 2006. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice. implications for its involvement in brain reward. Addict. Biol. 11, 45-54. (Pubitemid 46696736)
27. Jerlhag, E., Egecioglu, E., Dickson, S.L, Douhan, A., Svensson, L, Engel, JA, 2007. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict. Biol. 12, 6-16. (Pubitemid 46405994)
28. Jerlhag, E., Egecioglu, E., Dickson, S.L, Engel, JA, 2010. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 211, 415-422.
29. Jerlhag, E., Egecioglu, E., Dickson, S.L, Svensson, L, Engel, JA., 2008. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens. Eur. Neuropsychopharmacol. 18, 508-518.
30. Jerlhag, E., Egecioglu, E., Landgren, S., Salome, N., Heilig, M., Moechars, D., Datta, R., Perrissoud, D., Dickson, S.L, Engel, JA, 2009. Requirement of central ghrelin signaling for alcohol reward. Proc. Natl. Acad. Sci. USA 106, 11318-11323.
31. Jerlhag, E., Engel, J.A., 2011. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug Alcohol Depend. 117, 126-131.
32. Jerlhag, E., Janson, A.C., Waters, S., Engel, J.A., 2012. Concomitant release of ventral tegmental acetylcholine and accumbal dopamine by ghrelin in rats. PLoS One 7, e49557.
33. Jiang, H., Betancourt, L., Smith, R.G., 2006. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol. Endocrinol. 20, 1772-1785. (Pubitemid 44148083)
34. Klink, R., de Kerchove d'Exaerde, A., Zoli, M., Changeux, J.P., 2001. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21, 1452-1463. (Pubitemid 32182187)
35. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K., 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660. (Pubitemid 129516334)
36. Lanca, A.J., Adamson, K.L., Coen, K.M., Chow, B.L., Corrigall, W.A., 2000. The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96, 735-742. (Pubitemid 30155737)
37. Landgren, S., Engel, J.A., Hyytia, P., Zetterberg, H., Blennow, K., Jerlhag, E., 2011. Expression of the gene encoding the ghrelin receptor in rats selected for differential alcohol preference. Behav. Brain Res. 221, 182-188.
38. Larsson, A., Engel, J.A., 2004. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci. Biobehav. Rev. 27, 713-720. (Pubitemid 38202247)
39. Lecca, D., Shim, I., Costa, E., Javaid, J.I., 2000. Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats. Neuropharmacology 39, 88-98.
40. Luetje, C.W., 2004. Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release. Mol. Pharmacol. 65, 1333-1335. (Pubitemid 38668291)
41. Moon, M., Kim, H.G., Hwang, L., Seo, J.H., Kim, S., Hwang, S., Kim, S., Lee, D., Chung, H., Oh, M.S., Lee, K.T., Park, S., 2009. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 15, 332-347.
42. Narayanan, N.S., Guarnieri, D.J., DiLeone, R.J., 2010. Metabolic hormones, dopamine circuits, and feeding. Front. Neuroendocrinol. 31, 104-112.
43. Oades, R.D., Halliday, G.M., 1987. Ventral tegmental (A10) system: neurobiology. 1. anatomy and connectivity. Brain Res. 434, 117-165. (Pubitemid 17064083)
44. Pellegrino, L.J., Pellegrino, A.S., Cushman, A.J., 1979. A Stereotaxic Atlas of the Rat Brain, 2d ed. Plenum Press, New York.
45. Picciotto, M.R., 2003. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol. Sci. 24, 493-499. (Pubitemid 37088175)
46. Pidoplichko, V.I., Noguchi, J., Areola, O.O., Liang, Y., Peterson, J., Zhang, T., Dani, J.A., 2004. Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn. Mem. 11, 60-69. (Pubitemid 38167059)
47. Tanaka, M., Naruo, T., Muranaga, T., Yasuhara, D., Shiiya, T., Nakazato, M., Matsukura, S., Nozoe, S., 2002. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur. J. Endocrinol. 146, R1-3. (Pubitemid 34705084)
48. Teng, L., Crooks, P.A., Sonsalla, P.K., Dwoskin, L.P., 1997. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. J. Pharmacol. Exp. Ther. 280, 1432-1444. (Pubitemid 27166742)
49. Unger, M.M., Moller, J.C., Mankel, K., Eggert, K.M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P.H., Mayer, G., Tebbe, J.J., Oertel, W.H., 2011. Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease? J. Neurol. 258, 982-990.
50. Witten, I.B., Lin, S.C., Brodsky, M., Prakash, R., Diester, I., Anikeeva, P., Gradinaru, V., Ramakrishnan, C., Deisseroth, K., 2010. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 330, 1677-1681.
51. Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., Jones, I.W., 2000. Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur. J. Pharmacol. 393, 51-58. (Pubitemid 30193400)
52. Wonnacott, S., Sidhpura, N., Balfour, D.J., 2005. Nicotine: from molecular mechanisms to behaviour. Curr. Opin. Pharmacol. 5, 53-59. (Pubitemid 40124535)
53. Zhou, F.M., Wilson, C.J., Dani, J.A., 2002. Cholinergic interneuron characteristics and nicotinic properties in the striatum. J. Neurobiol. 53, 590-605. (Pubitemid 35375589)